ArticleJournal of cellular biochemistry2018

CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells.

Jia Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.